IQVIA Holdings Inc
(NYSE:IQV)
$
203.27
-1.05 (-0.51%)
Market Cap: 36.89 Bil
Enterprise Value: 48.88 Bil
PE Ratio: 26.68
PB Ratio: 5.30
GF Score: 90/100 
IQVIA Holdings Inc at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 05:10PM GMT
Release Date Price:
$207.92
(-0.03%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Thank you.
Questions & Answers
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers